337 related articles for article (PubMed ID: 20086153)
1. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.
Daniel A; Euler C; Collin M; Chahales P; Gorelick KJ; Fischetti VA
Antimicrob Agents Chemother; 2010 Apr; 54(4):1603-12. PubMed ID: 20086153
[TBL] [Abstract][Full Text] [Related]
2. A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains.
Pastagia M; Euler C; Chahales P; Fuentes-Duculan J; Krueger JG; Fischetti VA
Antimicrob Agents Chemother; 2011 Feb; 55(2):738-44. PubMed ID: 21098252
[TBL] [Abstract][Full Text] [Related]
3. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.
Gu J; Xu W; Lei L; Huang J; Feng X; Sun C; Du C; Zuo J; Li Y; Du T; Li L; Han W
J Clin Microbiol; 2011 Jan; 49(1):111-7. PubMed ID: 21048011
[TBL] [Abstract][Full Text] [Related]
4. The lytic activity of recombinant phage lysin LysKΔamidase against staphylococcal strains associated with bovine and human infections in the Jiangsu province of China.
Zhou Y; Zhang H; Bao H; Wang X; Wang R
Res Vet Sci; 2017 Apr; 111():113-119. PubMed ID: 28235706
[TBL] [Abstract][Full Text] [Related]
5. A Phage Lysin Fused to a Cell-Penetrating Peptide Kills Intracellular Methicillin-Resistant Staphylococcus aureus in Keratinocytes and Has Potential as a Treatment for Skin Infections in Mice.
Wang Z; Kong L; Liu Y; Fu Q; Cui Z; Wang J; Ma J; Wang H; Yan Y; Sun J
Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625989
[No Abstract] [Full Text] [Related]
6. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.
Gilmer DB; Schmitz JE; Euler CW; Fischetti VA
Antimicrob Agents Chemother; 2013 Jun; 57(6):2743-50. PubMed ID: 23571534
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro.
Dilworth TJ; Sliwinski J; Ryan K; Dodd M; Mercier RC
Antimicrob Agents Chemother; 2014; 58(2):1028-33. PubMed ID: 24277036
[TBL] [Abstract][Full Text] [Related]
8. Novel recombinant endolysin ointment with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from wounds and burns.
Hamed ZO; Awni AA; Abdulamir AS
Arch Microbiol; 2023 Mar; 205(4):104. PubMed ID: 36869962
[TBL] [Abstract][Full Text] [Related]
9. Exploiting Broad-Spectrum Chimeric Lysin to Cooperate with Mupirocin against Staphylococcus aureus-Induced Skin Infections and Delay the Development of Mupirocin Resistance.
Duan XC; Li XX; Li XM; Wang S; Zhang FQ; Qian P
Microbiol Spectr; 2023 Jun; 11(3):e0505022. PubMed ID: 37125939
[TBL] [Abstract][Full Text] [Related]
10. A potent enzybiotic against methicillin-resistant Staphylococcus aureus.
Kaur J; Singh P; Sharma D; Harjai K; Chhibber S
Virus Genes; 2020 Aug; 56(4):480-497. PubMed ID: 32367411
[TBL] [Abstract][Full Text] [Related]
11. Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivo.
Yang H; Zhang Y; Yu J; Huang Y; Zhang XE; Wei H
Antimicrob Agents Chemother; 2014; 58(1):536-42. PubMed ID: 24189265
[TBL] [Abstract][Full Text] [Related]
12. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11.
Rashel M; Uchiyama J; Ujihara T; Uehara Y; Kuramoto S; Sugihara S; Yagyu K; Muraoka A; Sugai M; Hiramatsu K; Honke K; Matsuzaki S
J Infect Dis; 2007 Oct; 196(8):1237-47. PubMed ID: 17955443
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.
Schuch R; Lee HM; Schneider BC; Sauve KL; Law C; Khan BK; Rotolo JA; Horiuchi Y; Couto DE; Raz A; Fischetti VA; Huang DB; Nowinski RC; Wittekind M
J Infect Dis; 2014 May; 209(9):1469-78. PubMed ID: 24286983
[TBL] [Abstract][Full Text] [Related]
14. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant
Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R
Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777
[TBL] [Abstract][Full Text] [Related]
15. Restoration of sensitivity of a diverse set of drug-resistant Staphylococcus clinical strains by bactericidal protein P128.
Nair S; Poonacha N; Desai S; Hiremath D; Tuppad D; Mohan T; Chikkamadaiah R; Durgaiah M; Kumar S; Channabasappa S; Vipra A; Sharma U
J Med Microbiol; 2018 Mar; 67(3):296-307. PubMed ID: 29458674
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
17. Combination Therapy of LysGH15 and Apigenin as a New Strategy for Treating Pneumonia Caused by Staphylococcus aureus.
Xia F; Li X; Wang B; Gong P; Xiao F; Yang M; Zhang L; Song J; Hu L; Cheng M; Sun C; Feng X; Lei L; Ouyang S; Liu ZJ; Li X; Gu J; Han W
Appl Environ Microbiol; 2016 Jan; 82(1):87-94. PubMed ID: 26475103
[TBL] [Abstract][Full Text] [Related]
18. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin.
Jiang W; Li B; Zheng X; Liu X; Cen Y; Li J; Pan X; Cao H; Zheng J; Zhou H
Int Immunopharmacol; 2011 Aug; 11(8):1065-73. PubMed ID: 21396483
[TBL] [Abstract][Full Text] [Related]
19. Nationwide Organism Susceptibility Patterns to Common Preoperative Prophylactic Antibiotics: What Are We Covering?
Nodzo SR; Boyle KK; Frisch NB
J Arthroplasty; 2019 Jul; 34(7S):S302-S306. PubMed ID: 30745218
[TBL] [Abstract][Full Text] [Related]
20. An Ointment Consisting of the Phage Lysin LysGH15 and Apigenin for Decolonization of Methicillin-Resistant
Cheng M; Zhang L; Zhang H; Li X; Wang Y; Xia F; Wang B; Cai R; Guo Z; Zhang Y; Ji Y; Sun C; Feng X; Lei L; Yang Y; Han W; Gu J
Viruses; 2018 May; 10(5):. PubMed ID: 29734776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
